Fact CheckerSign in

NCT07430254Not yet recruiting

Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia

Finger Plethysmographic Cardiac Output Monitoring to Predict Fluid Responsiveness in Healthy Pregnancy and Women Diagnosed With Preeclampsia and Severe Features

Source: ClinicalTrials.gov · Last updated 24 Feb 2026

Brief summary (registry, in English)

The goal of this observational study is to determine whether noninvasive finger plethysmographic cardiac output monitoring can help predict fluid responsiveness in pregnant women, including those with preeclampsia with severe features. The main questions it aims to answer are : * Can changes in cardiac output measured by finger plethysmography predict fluid responsiveness? * How does this method perform compared with standard echocardiographic assessment? Participants will provide consent and undergo noninvasive hemodynamic monitoring and a brief reversible physiological challenge.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
88 (estimated)
First submitted
18 Feb 2026
Start date
Jul 2026
Primary completion date
Jul 2028
Lead sponsor
Stanford University
NCT number
NCT07430254

What you commit to

  • Study type: Observational
  • Planned participants: 88
  • From Jul 2026 to the primary completion date, Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Non-reassuring fetal heart tracing
  • History of chronic arterial hypertension
  • Chronic kidney disease
  • Congenital or known acquired heart disease
  • Chronic obstructive pulmonary disease
  • Diabetes
  • History of stroke

Other

  • Patients who can not provide written consent to participate in the study
  • BMI greater than 40 kg/m²
  • Multiple pregnancy (twins, triplets, etc.)
  • ≤ 22 weeks gestation
  • Not tolerating passive leg raising (unable to be placed in the required study position)
  • No TTE-windows
  • Withdrawing consent
  • Emergency cesarean delivery

Who the study is looking for

  • Women diagnosed with preeclampsia with severe features following ACOG recommendations (systolic/diastolic BP \>160/110 mmHg, proteinuria, or other severe features like headaches, visual disturbances, kidney/liver impairment, thrombocytopenia).
  • Healthy pregnant women at term (for comparison group, e.g., scheduled for elective Cesarean delivery).

Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lucile Packard Children's Hospital
Coordinator of this site? Confirm its status
Palo AltoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.